PMID- 35549801 OWN - NLM STAT- MEDLINE DCOM- 20230508 LR - 20230513 IS - 1464-5165 (Electronic) IS - 0963-8288 (Linking) VI - 45 IP - 10 DP - 2023 May TI - Minimal clinically important difference of the King's Parkinson's disease Pain Scale. PG - 1680-1683 LID - 10.1080/09638288.2022.2074152 [doi] AB - OBJECTIVE: Pain is a common and debilitating symptom of Parkinson's disease (PD) and has no specific treatment. King's Parkinson's disease Pain Scale (KPPS) is the only specific scale for pain measurement in PD with established psychometric properties. The minimal clinically important difference (MCID) of KPPS, an important parameter for the design and interpretation of therapeutic interventions, has not yet been measured. The aim of our study was to assess the MCID of KPPS. METHODS: Two hundred and seven PD patients were evaluated by KPPS before and after receiving the intervention. The Clinical Global Impression of Improvement Scale was used as an anchor, and a Receiver Operating Characteristic (ROC) curve was used to determine the optimal MCID cut-off point for KPPS. The distribution-based approach applied one-third standard deviation (SD), 0.5 SD, and one standard error of measurement (SEM) of the total score of KPPS to determine the MCID. RESULTS: The MCID achieved from the ROC curve was 3 points (sensitivity: 74.4%; specificity: 81.9%). For the distribution-based method, the MCIDs corresponding to 0.3 SD, 0.5 SD, and one SEM were 5.65, 9.41, and 2.54 points, respectively. CONCLUSION: KPPS is a valid scale for measuring pain in PD with demonstrable MCID. IMPLICATIONS FOR REHABILITATIONThe King's Parkinson's disease Pain Scale (KPPS) is a valid scale for measuring pain in patients with Parkinson's disease (PD) with demonstrable minimal clinically important difference (MCID).The MCID obtained in the current study will assist clinicians and researchers when interpreting KPPS change score to determine clinically meaningful changes of pain in both PD progression and response to interventions. FAU - Taghizadeh, Ghorban AU - Taghizadeh G AUID- ORCID: 0000-0002-0145-9599 AD - Department of Occupational Therapy, School of Rehabilitation Sciences, Rehabilitation Research Center, Iran University of Medical Science, Tehran, Iran. FAU - Fereshtehnejad, Seyed-Mohammad AU - Fereshtehnejad SM AD - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden. AD - Division of Neurology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. FAU - Goudarzi, Sepideh AU - Goudarzi S AUID- ORCID: 0000-0001-8545-8560 AD - Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran. FAU - Jamali, Shamsi AU - Jamali S AD - Department of Occupational Therapy, School of Rehabilitation Sciences, Rehabilitation Research Center, Iran University of Medical Science, Tehran, Iran. FAU - Mehdizadeh, Maryam AU - Mehdizadeh M AUID- ORCID: 0000-0003-2977-3421 AD - Department of Neurosciences, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran. LA - eng PT - Journal Article DEP - 20220512 PL - England TA - Disabil Rehabil JT - Disability and rehabilitation JID - 9207179 SB - IM MH - Humans MH - Pain Measurement MH - *Minimal Clinically Important Difference MH - *Parkinson Disease/complications/diagnosis MH - Psychometrics MH - Pain/diagnosis/etiology MH - Treatment Outcome OTO - NOTNLM OT - Anchor-based OT - Distribution-based OT - Minimal clinically important difference OT - Pain OT - Parkinson's disease EDAT- 2022/05/14 06:00 MHDA- 2023/05/08 06:41 CRDT- 2022/05/13 12:08 PHST- 2023/05/08 06:41 [medline] PHST- 2022/05/14 06:00 [pubmed] PHST- 2022/05/13 12:08 [entrez] AID - 10.1080/09638288.2022.2074152 [doi] PST - ppublish SO - Disabil Rehabil. 2023 May;45(10):1680-1683. doi: 10.1080/09638288.2022.2074152. Epub 2022 May 12.